Jason Wittes

Stock Analyst at Roth MKM

(3.16)
# 1,065
Out of 4,847 analysts
62
Total ratings
50%
Success rate
0.44%
Average return

Stocks Rated by Jason Wittes

Stryker
May 2, 2025
Maintains: Buy
Price Target: $405$456
Current: $381.01
Upside: +19.68%
Allurion Technologies
Mar 21, 2025
Reiterates: Buy
Price Target: $16
Current: $2.85
Upside: +461.40%
Monogram Technologies
Mar 18, 2025
Maintains: Buy
Price Target: $4$5.4
Current: $2.40
Upside: +125.00%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15$16
Current: $1.84
Upside: +769.57%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $11.08
Upside: +98.65%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60$72
Current: $59.43
Upside: +21.15%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $5.29
Upside: +107.94%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100$115
Current: $59.70
Upside: +92.63%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $7.69
Upside: +368.14%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $7.24
Upside: +51.93%
Initiates: Buy
Price Target: $10
Current: $1.31
Upside: +663.36%
Reinstates: Buy
Price Target: $100
Current: $82.51
Upside: +21.20%
Reiterates: Buy
Price Target: $5
Current: $2.29
Upside: +118.34%
Initiates: Buy
Price Target: $9
Current: $1.57
Upside: +473.25%
Initiates: Buy
Price Target: $75
Current: $30.68
Upside: +144.46%
Initiates: Buy
Price Target: $22
Current: $12.65
Upside: +73.91%
Initiates: Neutral
Price Target: $120
Current: $91.85
Upside: +30.65%
Initiates: Buy
Price Target: $206
Current: $164.06
Upside: +25.56%
Reinstates: Buy
Price Target: $145
Current: $217.21
Upside: -33.24%
Initiates: Buy
Price Target: $15
Current: $10.21
Upside: +46.91%
Initiates: Buy
Price Target: $200
Current: $17.04
Upside: +1,073.71%
Initiates: Buy
Price Target: $26
Current: $36.41
Upside: -28.59%